Mushrooms Inc. (MSRM)
Mushrooms Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Estero, FL, US. The stock last traded at $0.01, down 8.44% on the session, giving a market capitalisation of $236,749. On trailing twelve-month figures it carries a trailing P/E of -4.41, a net margin of -6713.1%. Its beta of 1.51 implies it has historically moved more than the broad market.
Mushrooms, Inc. is a biotechnology company that develops products from mushrooms and mycelium. The company focuses on mycelium's industrial applications for carbon-neutral products, health supplements, and technologies for healthcare and textiles, such as bacterial detection and nutrient delivery. The company was formerly known as Marijuana Strategic Ventures Inc. and changed its name to Mushrooms Inc. in October 2022. [20, 22, 28, 33]
Mushrooms Inc. is most often compared with the following Healthcare names: